Literature DB >> 21607290

B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.

Alessandro Michelutti1, Elisa Gremese, Francesca Morassi, Luca Petricca, Vincenzo Arena, Barbara Tolusso, Stefano Alivernini, Giusy Peluso, Silvia Laura Bosello, Gianfranco Ferraccioli.   

Abstract

The aim of the present study was to determine whether different subsets of B cells characterize synovial fluid (SF) or synovial tissue (ST) of seropositive or seronegative rheumatoid arthritis (RA) with respect to the peripheral blood (PB). PB, SF and ST of 14 autoantibody (AB)-positive (rheumatoid factor [RF]-IgM, RF-IgA, anti-citrullinated peptide [CCP]), 13 negative RA and 13 no-RA chronic arthritides were examined for B-cell subsets (Bm1-Bm5 and IgD-CD27 classifications), zeta-associated protein kinase-70 (ZAP70) expression on B cells and cytokine levels (interleukin [IL]-1β, tumor necrosis factor [TNF]-α, IL-6, IL-8 and monocyte chemotactic protein [MCP]-1). Synovial tissues were classified as aggregate and diffuse patterns. No differences were found in B-cell percentages or in subsets in PB and SF between AB(+) and AB(-) RA and no-RA. In both AB(+) and AB(-) RA (and no-RA), the percentage of CD19(+)/ZAP70(+) was higher in SF than in PB (AB(+): P = 0.03; AB(-): P = 0.01; no-RA: P = 0.01). Moreover, SF of both AB(+) and AB(-) RA (and no-RA) patients was characterized by a higher percentage of IgD-CD27(+) and IgD-CD27(-) B cells and lower percentage of IgD(+)CD27(-) (P < 0.05) B cells compared to PB. In SF, ZAP70 positivity is more represented in B cell CD27(+)/IgD(-)/CD38(-). The aggregate synovitis pattern was characterized by higher percentages of Bm5 cells in SF compared with the diffuse pattern (P = 0.05). These data suggest that no difference exists between AB(+) and AB(-) in B-cell subset compartmentalization. CD27(+)/IgD(-)/ZAP70(+) memory B cells accumulate preferentially in the joints of RA, suggesting a dynamic maturation of the B cells in this compartment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21607290      PMCID: PMC3188870          DOI: 10.2119/molmed.2011.00034

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  25 in total

Review 1.  Phenotypic and functional heterogeneity of human memory B cells.

Authors:  Iñaki Sanz; Chungwen Wei; F Eun-Hyung Lee; Jennifer Anolik
Journal:  Semin Immunol       Date:  2008-02-06       Impact factor: 11.130

2.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

3.  Tissue cytokine patterns distinguish variants of rheumatoid synovitis.

Authors:  P A Klimiuk; J J Goronzy; J Björ nsson; R D Beckenbaugh; C M Weyand
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients.

Authors:  K Shi; K Hayashida; M Kaneko; J Hashimoto; T Tomita; P E Lipsky; H Yoshikawa; T Ochi
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

5.  B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis.

Authors:  Tineke Cantaert; Johanna Kolln; Trieneke Timmer; Tineke C van der Pouw Kraan; Bernard Vandooren; Rogier M Thurlings; Juan D Cañete; Anca I Catrina; Theo Out; Cor L Verweij; Yiping Zhang; Paul P Tak; Dominique Baeten
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Authors:  Marta Crespo; Francesc Bosch; Neus Villamor; Beatriz Bellosillo; Dolors Colomer; María Rozman; Silvia Marcé; Armando López-Guillermo; Elies Campo; Emili Montserrat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

7.  Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.

Authors:  Annett M Jacobi; Karin Reiter; Meggan Mackay; Cynthia Aranow; Falk Hiepe; Andreas Radbruch; Arne Hansen; Gerd-R Burmester; Betty Diamond; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Rheum       Date:  2008-06

8.  Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results.

Authors:  A Kavanaugh; S Rosengren; S J Lee; D Hammaker; G S Firestein; K Kalunian; N Wei; D L Boyle
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

9.  Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis.

Authors:  Shouvik Dass; Andy C Rawstron; Edward M Vital; Karen Henshaw; Dennis McGonagle; Paul Emery
Journal:  Arthritis Rheum       Date:  2008-10

10.  Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.

Authors:  R M Thurlings; K Vos; C A Wijbrandts; A H Zwinderman; D M Gerlag; P P Tak
Journal:  Ann Rheum Dis       Date:  2007-10-26       Impact factor: 19.103

View more
  15 in total

1.  Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA).

Authors:  Gianfranco Ferraccioli; Elisa Gremese
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients.

Authors:  Yeniley Ruiz-Noa; Jorge Hernández-Bello; Mara A Llamas-Covarrubias; Claudia A Palafox-Sánchez; Edith Oregon-Romero; Pedro Ernesto Sánchez-Hernández; Maria Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Jose Francisco Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2018-11-06       Impact factor: 2.352

3.  Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.

Authors:  Ted R Mikuls; Michael J Duryee; Rafid Rahman; Daniel R Anderson; Harlan R Sayles; Andrew Hollins; Kaleb Michaud; Frederick Wolfe; Geoffrey E Thiele; Jeremy Sokolove; William H Robinson; Nithya Lingampalli; Anthony P Nicholas; Geoffrey A Talmon; Kaihong Su; Matthew C Zimmerman; Lynell W Klassen; Geoffrey M Thiele
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

4.  Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

Authors:  Erica L Eggers; Brady A Michel; Hao Wu; Sheng-Zhi Wang; Carolyn J Bevan; Aya Abounasr; Natalie S Pierson; Antje Bischof; Max Kazer; Elizabeth Leitner; Ariele L Greenfield; Stanislas Demuth; Michael R Wilson; Roland G Henry; Bruce Ac Cree; Stephen L Hauser; H-Christian von Büdingen
Journal:  JCI Insight       Date:  2017-11-16

Review 5.  Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission.

Authors:  Mariola Kurowska-Stolarska; Stefano Alivernini
Journal:  Nat Rev Rheumatol       Date:  2022-06-07       Impact factor: 32.286

6.  Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.

Authors:  Ali Khanzadeh; Zahra Habibagahi; Ahmad Hosseini; Zahra Amirghofran
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

7.  Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.

Authors:  Anna Laura Fedele; Barbara Tolusso; Elisa Gremese; Silvia Laura Bosello; Angela Carbonella; Silvia Canestri; Gianfranco Ferraccioli
Journal:  BMC Immunol       Date:  2014-09-04       Impact factor: 3.615

8.  Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.

Authors:  Gabriele Di Sante; Barbara Tolusso; Anna Laura Fedele; Elisa Gremese; Stefano Alivernini; Chiara Nicolò; Francesco Ria; Gianfranco Ferraccioli
Journal:  EBioMedicine       Date:  2015-11-17       Impact factor: 8.143

9.  High levels of memory B cells are associated with response to a first tumor necrosis factor inhibitor in patients with rheumatoid arthritis in a longitudinal prospective study.

Authors:  Claire I Daien; Sarah Gailhac; Thibault Mura; Bernard Combe; Michael Hahne; Jacques Morel
Journal:  Arthritis Res Ther       Date:  2014-04-15       Impact factor: 5.156

10.  Analysis of serum immune markers in seropositive and seronegative rheumatoid arthritis and in high-risk seropositive arthralgia patients.

Authors:  Paulina Chalan; Johan Bijzet; Anke van den Berg; Joost Kluiver; Bart-Jan Kroesen; Annemieke M H Boots; Elisabeth Brouwer
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.